Recognizing these signs can help individuals seek timely medical intervention, which is vital for effective treatment and recovery
Who GLP-1 weight loss is for - and who it isn't Patients we typically work with on GLP-1 weight management: Adults with BMI 30+ (obesity) who have not achieved sustained weight loss with lifestyle change alone Adults with BMI 27+ and weight-related comorbidities - type 2 diabetes, hypertension, dyslipidemia, sleep apnea, prediabetes, fatty liver disease Patients with insulin resistance or metabolic syndrome where the metabolic and weight pictures are intertwined Patients post-bariatric surgery with weight regain, where appropriate and coordinated with their surgical team GLP-1 medications are not appropriate for patients with personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, severe gastroparesis, or active eating disorders
Melanotan I (afamelanotide, brand Scenesse) selectively targets MC1R for tanning with fewer side effects and is EU-approved for erythropoietic protoporphyria
We only have early data right now, and we need more studies to fully understand how weight loss drugs can help skin diseases, notes Dr
Protect from light and avoid freeze-thaw cycles
Abstract Impaired redox metabolism is a key contributor to the etiology of many diseases, including primary mitochondrial disorders, cancer, neurodegeneration and aging